Differential Epigenome-Wide Association Study — Differential EWAS
Differential Epigenome-Wide Association Study (Differential EWAS) · Also known as: Differential EWAS, comparative EWAS, epigenome-wide differential methylation analysis, EWAS differential design
A Differential Epigenome-Wide Association Study (Differential EWAS) scans hundreds of thousands of CpG methylation sites across the genome to identify those whose methylation levels differ significantly between two or more comparison groups — such as cases vs. controls, exposed vs. unexposed, or distinct developmental stages. It is the standard epigenomic analogue of a differential expression analysis but operates at the level of DNA methylation marks rather than RNA counts.
Read the full method
Sign in with a free account to read this section.
Method map
The neighbourhood of related methods — select a node to explore.
When to use it
Use Differential EWAS when the research question is: which specific methylation sites or regions differ between defined biological groups, and do those differences associate with a trait or exposure? It is appropriate for case-control studies of common disease, developmental biology, environmental epigenomics (e.g., smoking, diet), and pharmacoepigenomics. Required inputs are Illumina 450K/EPIC array data or whole-genome bisulfite sequencing with adequate sample sizes (typically n ≥ 50 per group for modest effect sizes). Do NOT use it when the groups are not clearly defined, when sample sizes are very small (n < 20 per group), when you lack information to correct for cell-type heterogeneity in mixed tissues, or when the goal is to characterise the absolute methylation landscape rather than a between-group contrast. For longitudinal single-cell epigenomics the method requires adaptation.
Strengths & limitations
- Provides unbiased, hypothesis-free scanning of the entire methylome for group differences.
- Array-based platforms (450K, EPIC) offer high reproducibility, broad coverage, and affordable cost.
- Regional aggregation methods (DMRs) boost power and biological interpretability over single-site tests.
- Results integrate naturally with GWAS and transcriptomics for multi-omics triangulation.
- DNA methylation differences between groups are often small (delta-beta < 0.10), requiring large sample sizes to achieve adequate power.
- Cell-type heterogeneity in bulk tissue is a major confounder; correction is imperfect when reference panels do not match the tissue studied.
- Array platforms cover only a fraction of all CpG sites; whole-genome bisulfite sequencing is needed for complete coverage but is expensive.
- Observed methylation differences may be consequence rather than cause of the phenotype; causal inference requires additional designs (e.g., Mendelian randomisation).
Frequently asked
What is the difference between a DMP and a DMR?
A differentially methylated position (DMP) is a single CpG site that passes the significance threshold. A differentially methylated region (DMR) is a contiguous stretch of CpGs that collectively show consistent differential methylation. DMRs are detected by tools such as bumphunter or DMRcate, which aggregate single-site statistics spatially. DMRs generally replicate better and are more interpretable in relation to gene regulatory elements than isolated DMPs.
How large a sample do I need?
Power depends on the expected effect size (delta-beta), the number of CpGs tested, and the significance threshold. As a rough guide, detecting sites with delta-beta of 0.05–0.08 at genome-wide significance typically requires n ≥ 100–200 per group. The EWAS Power Calculator or simulation-based approaches provide study-specific estimates. Under-powered studies are a major reproducibility concern in the field.
Should I use beta-values or M-values in the regression?
M-values (logit transform of beta-values) are statistically preferable for linear regression because they approximate homoscedasticity, whereas beta-values violate the variance-stability assumption at extreme methylation levels. However, beta-values (range 0–1) are more interpretable biologically. Best practice is to fit models on M-values and report effect sizes as delta-beta (difference in average beta-values between groups).
Do I need to replicate my findings?
Yes. Even after genome-wide significance correction, replication in an independent cohort is strongly recommended because Bonferroni correction does not fully control for systematic confounders. Replication in a different population or platform strengthens confidence that a hit is a genuine biological signal rather than a batch or population-specific artefact.
How does Differential EWAS differ from standard EWAS?
Standard EWAS typically tests for association between methylation at each CpG and a continuous or binary trait in a single population. Differential EWAS specifically frames the question as a between-group contrast (e.g., cases vs. controls, treated vs. untreated) and may use designs — such as matched pairs or longitudinal sampling — optimised for detecting that contrast. The distinction is primarily conceptual and analytical; the core pipeline is the same.
Sources
- Rakyan, V. K., Down, T. A., Balding, D. J., & Beck, S. (2011). Epigenome-wide association studies for common human diseases. Nature Reviews Genetics, 12(8), 529–541. link ↗
- Jaffe, A. E., & Irizarry, R. A. (2014). Accounting for cellular heterogeneity is critical in epigenome-wide association studies. Genome Biology, 15(2), R31. link ↗
How to cite this page
ScholarGate. (2026, June 3). Differential Epigenome-Wide Association Study (Differential EWAS). ScholarGate. https://scholargate.app/en/bioinformatics/differential-epigenome-wide-association-study
Which method?
Set this method beside its closest kin and read them side by side — the library lays the books on the table; the choice is yours.
- ChIP-seq Peak CallingBioinformatics↔ compare
- Copy Number Variation AnalysisBioinformatics↔ compare
- Epigenome-wide association studyBioinformatics↔ compare
- Genome-wide association studyBioinformatics↔ compare
- Pathway Enrichment AnalysisBioinformatics↔ compare
- RNA-seq Differential ExpressionBioinformatics↔ compare